Leukemia Research
Volume 27, Issue 1 , Pages 19-21 , January 2003

The effect of short-course high-dose methylprednisolone on peripheral blood lymphocyte subsets in children with acute leukemia during remission induction treatment

Received 6 March 2002 ,Accepted 1 April 2002.

References 

  1. Shanbrom E, Miller S. Critical evaluation of massive steroid therapy of acute leukemia. N Engl J Med. 1962;266:1354
  2. Hicsonmez G, Ozsoylu S, Onat N, Zamani VP, Gumruk F, Tuncer AM. High-dose methylprednisolone in resistant and relapsed children with acute lymphoblastic leukemia. Med Pediatr Oncol. 1994;22:68
  3. Ryalls MR, Pinkerton CR, Meller ST, Tablot D, McElvan TJ. High-dose methylprednisolone sodium succinate as a single agent in relapsed childhood acute lymphoblastic leukemia. Med Pediatr Oncol. 1992;20:119
  4. Hicsonmez G, Gumruk F, Zamani PV, Tuncer AM, Yetgin S, Gurgey A, et al.  High-dose methylprednisolone for children with acute lymphoblastic leukemia and unfavorable presenting features. Eur J Haematol. 1997;58:26
  5. Yetgin S, Gurgey A, Tuncer AM, Cetin M, Ozbek N, Saylý T, et al.  Acomparison of the effect of high-dose methylprednisolone with conventional-dose prednisolone in acute lymhoblastic leukemia children with randomization. Leuk Res. 1998;22:485
  6. Hicsonmez G, Tuncer AM, Toksoy HB, Yenicesu I, Cetin M. Differentiation of myeloid leukemic cells induced by high-dose methylprednisolone in children with different subtypes of acute myeloblastic leukemia. Leuk Lymphoma. 1999;33:573
  7. Hicsonmez G, Erdemli E, Tekelioglu M, Tuncer AM, Ozbek N, Cetin M. Morphologic evidence of apoptosis in chidren with acute myeloblastic leukemia treated by high-dose methylprednisolone. Leuk Lymphoma. 1996;22:91
  8. Ozbek N, Erdemli E, Hicsonmez G, Okur H, Tekelioglu M. Effects of methylprednisolone on human myeloid leukemic cells in vitro. Am J. Hematol. 1999;60:255
  9. Hicsonmez G, Onat N, Albayrak D, Yetgin S, Ozsoylu S. Acceleration of leukecyte recovery by administration of short-course high-dose methylprednisolone in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 1991;8:193
  10. Tuncer AM, Hicsonmez G, Gumruk F, Albayrak D, Duru F, Guler E, et al.  The effect of high-dose methylprednisolone combined chemotherapy on CD34 positive cells in acute lymphoblastic leukemia. Hematol Pathol. 1994;8:169
  11. Tuncer AM, Hicsonmez G, Gumruk F, Albayrak D, Duru F, Guler E, et al.  The effects of high-dose methylprednisolone on CD34-positive bone marrow cells in children with acute myeloblastic leukemia. Turk J Pediatr. 1995;37:345
  12. Cetin M, Hicsonmez G, Tuncer AM, Kansu E, Canpýnar H. The effect of short-course high-dose corticosteroid therapy on peripheral blood CD34+ progenitor cells in children with acute leukemia. Exp Hematol. 1996;24:1191
  13. Rothe G, Schmitz G. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Leukemia. 1996;10:877
  14. Tuncer AM, Ozsoylu S, Ersoy F, Yeniay I. The effects of glucocorticoids on lymphocyte numbers. Immunol Today. 1991;12:207
  15. Ozbek N, Yetgin S, Tuncer AM. Effect of high-dose methylprednisolone and G-CSF treatments on lymphocyte subtypes in neutropenic children with acute lymphoblastic leukemia: a pilot study. Pediatr Hematol Oncol. 1998;15:539
  16. Ayroldi E, Cannarile L, D’Adamio F, Riccardi C. Superantigen-induced peripheral T cell deletion: the effects of chemical modification of antigen presenting cells, interleukin-4 and glucocorticoid hormones. Immunology. 1995;84:528
  17. Tunc B, Oner AF, Hicsonmez G. The effect of short-course high-dose methylprednisolone on peripheral blood CD34+ progenitor cells of children with acute leukemia during remission induction therapy. Turk J Pediatr. 2002;44:1
  18. Tuncer AM, Hicsonmez G, Erturk G, Gumruk F, Albayrak D, Oguz H. The effect of high-dose methylprednisolone treatment on GM-CSF level in children with acute leukemia: a pilot study. Leuk Res. 1992;16:615
  19. Tuncer AM, Hicsonmez G, Gumruk F, Saylý T, Guler E, Cetin M, et al.  Serum TNF-alfa, gamma-INF, G-CSF levels in neutropenic children with acute leukemia treated with short-course, high-dose methylprednisolone. Leuk Res. 1996;20:265
  20. Yenicesu I, Hicsonmez G, Tuncer AM. Effect of short-course high-dose methylprednisolone treatment on serum IL-2 levels in children with myelodysplastic syndromes: a pilot study. Leuk Res. 1997;21:789
  21. Fauci AS, Dale DC. The effect of in vivo hydrocortisone on subsets of human lymphocytes. J Clin Invest. 1974;53:240
  22. Saunders ME, Makgoba MV, Shaw S. Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol Today. 1988;9:195
  23. Shah VO, Civin CI, Loken MR. Flow cytometric analysis of human bone marrow. IV. Differential quantitative expression of T-200 common leukocyte antigen during normal hematopoiesis. J Immunol. 1988;140:1861
  24. Nasrallah AG, Giancotti FG. Natural killer activity in children with untreated acute leukemia. Cancer Res. 1983;43:5580

☆ From the Hematology Unit, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara.

PII: S0145-2126(02)00074-7

Leukemia Research
Volume 27, Issue 1 , Pages 19-21 , January 2003

Article Tools

* Image Usage & Resolution